240 related articles for article (PubMed ID: 6970027)
21. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.
Mazzoccoli G; Balzanelli M; Giuliani A; De Cata A; La Viola M; Carella AM; Bianco G; Tarquini R
In Vivo; 1999; 13(3):205-9. PubMed ID: 10459492
[TBL] [Abstract][Full Text] [Related]
22. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
[No Abstract] [Full Text] [Related]
23. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
24. [A method of detecting atypical cells in the blood of lung cancer patients].
Sergel' OS; Adamian AA; Kachkov AP
Eksp Khir Anesteziol; 1969; 14(6):39-44. PubMed ID: 4318160
[No Abstract] [Full Text] [Related]
25. "Assessment of cellular immunity in patients with carcinoma of lung".
Shanker R; Agarwal BM; Singh SN; Rajvanshi VS; Chandra T
Indian J Pathol Microbiol; 1981 Apr; 24(2):83-8. PubMed ID: 6974695
[No Abstract] [Full Text] [Related]
26. Immune response of regional lymph nodes in patients with lung cancer.
Ogawa J; Inoue H; Koide S; Kawada S; Shohtsu A
Tokai J Exp Clin Med; 1981 Jul; 6(3):259-66. PubMed ID: 6975508
[TBL] [Abstract][Full Text] [Related]
27. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
Tatsuno I; Konishi K
Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
[No Abstract] [Full Text] [Related]
28. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
29. [Immunological index changes in the surgical treatment of lung cancer].
Kotliarov EV; Bekhtereva EI; Rask RE; Kriukova LI
Klin Khir (1962); 1981 Oct; (10):10-2. PubMed ID: 6975852
[No Abstract] [Full Text] [Related]
30. Failure of cell-mediated effector mechanisms in lung cancer.
Feo Figarella E; Morillo F; Blanca I; Bianco NE
J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
[TBL] [Abstract][Full Text] [Related]
31. Treatment of cancer patients with autologous lymphocytes pre-incubated with T.F. from long survivors.
Fazio M; Negri L; Mastromatteo V; Pacchioni D; Calabrese F; Giacomasso S
J Exp Pathol; 1987; 3(4):569-77. PubMed ID: 3454804
[No Abstract] [Full Text] [Related]
32. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
[TBL] [Abstract][Full Text] [Related]
33. [Immunological aspects of lung cancer].
Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
[No Abstract] [Full Text] [Related]
34. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
[TBL] [Abstract][Full Text] [Related]
35. [Droperidol, seduxen, fentanyl: a study of immune reactions in vitro].
Gadalov VP; Filatov PP; Medvedev VN; Malik SS
Anesteziol Reanimatol; 1989; (4):18-21. PubMed ID: 2817492
[TBL] [Abstract][Full Text] [Related]
36. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
37. Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.
Prado-Garcia H; Aguilar-Cazares D; Flores-Vergara H; Mandoki JJ; Lopez-Gonzalez JS
Lung Cancer; 2005 Mar; 47(3):361-71. PubMed ID: 15713519
[TBL] [Abstract][Full Text] [Related]
38. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
39. The activity of neutrophil myeloperoxidase in patients with lung carcinoma.
Dabrowska M; Prokopowicz J; Pietruczuk M; Kemona H; Wołosowicz N; Kiluk S; Głuszczak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):613-9. PubMed ID: 2465241
[TBL] [Abstract][Full Text] [Related]
40. [Cell-mediated immune reactivity in patients with lung carcinoma].
Szczepaniec M
Pneumonol Pol; 1979 May; 47(5):301-9. PubMed ID: 314104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
